You just read:

NICO Announces First Patient Enrolled in Phase 3 Randomized Controlled Trial on Early Intervention of Hemorrhagic Stroke, Deadliest Form of Stroke

News provided by

NICO Corporation

10 Jan, 2017, 07:10 ET